臨床眼科77巻4号

2023年04月発行

特集 第76回日本臨床眼科学会講演集［2］ 特別講演

緑内障眼における前房隅角の病態診断と治療介入

著者： 久保田敏昭¹

所属機関： ¹大分大学医学部眼科学講座

ページ範囲：P.415 - P.429

　原発緑内障の3臨床病型において線維柱帯の未熟性は連続しており，原発先天緑内障，若年開放隅角緑内障，原発開放隅角緑内障の順に未熟性が低下して，より高齢になって緑内障が発症する。続発緑内障のうち血管新生緑内障，落屑緑内障の病態について解説する。古典的な隅角部位の手術である線維柱帯切除術は，いまでも進行期の緑内障眼には必要であり，その多数例での成績も大事な情報である。Minimally invasive glaucoma surgeryは結膜への低侵襲性で注目され，なかでも眼内アプローチ流出路手術は，緑内障早期に行える手術の位置を確立したといえる。また同じような立ち位置でselective laser trabeculoplastyも最近注目されている。

参考文献

1）Ren R, Li G, Le TD et al：Netarsudil increases outflow facility in human eyes through multiple mechanisms. Invest Ophthalmol Vis Sci 57：6197-6209, 2016

2）Huang AS, Penteado RC, Saha SK et al：Fluorescein aqueous angiography in live normal human eyes. J Glaucoma 27：957-964, 2018

3）Rohen JW, Lütjen-Drecoll E, Flügel C et al：Ultrastructure of the trabecular meshwork in untreated cases of primary open-angle glaucoma（POAG）. Exp Eye Res 56：683-692, 1993

ed.）. p89-123, Mosby, St. Louis, 1996

5）Tawara A, Inomata H：Developmental immaturity of the trabecular meshwork in congenital glaucoma. Am J Ophthalmol 92：508-525, 1981.

6）Tawara A, Inomata H, Tsukamoto S：Ciliary body bandwidth as an indicator of goniodysgenesis. Am J Ophthalmol 122：790-800, 1996

7）Aiello LP, Avery RL, Arrigg PG et al：Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331：1480-1487, 1994

8）Gartner S, Henkind P：Neovascularization of the iris（rubeosis iridis）. Surv Ophthalmol 22：291-312, 1978

9）Kubota T, Tawara A, Hata Y et al：Neovascular tissue in the intertrabecular spaces in eyes with neovascular glaucoma. Br J Ophthalmol 80：750-754, 1996

10）Wakabayashi T, Oshima Y, Sakaguchi H et al：Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal disease in 41 consecutive cases. Ophthalmology 115：1571-1580, 2008

11）Kubota T, Aoki R, Harada Y et al：Intravitreal injection of bevacizumab to treat neovascular glaucoma. Jpn J Ophthalmol 52：410-412, 2008

12）Inatani M, Higashide T, Matsushita K et al：Intravitreal Aflibercept in Japanese Patients with Neovascular Glaucoma：The VEGA Randomized Clinical Trial. Adv Ther, 38：1116-1129, 2021

13）Ishibashi S, Tawara A, Sohma R et al：Angiographic changes in iris and iridocorneal angle neovascularization after intravitreal bevacizumabinjection. Arch Ophthalmol 128：1539-1545, 2010

14）Kubota T, Aoki R, Harada Y et al：Trabecular meshwork in neovascular glaucoma eyes after the intravitreal injection of bevacizumab. Br J Ophthalmol 93：557-558, 2009

15）Elschnig A：Ablösung der zonula lamella bei Glasblaserm I. Klin Monatsbl Augenheilkd 69：732-734, 1922

16）Naumann GO, Schlötzer-Schrehardt U, Küchle M：Pseudoexfoliation syndrome for the comprehensive ophthalmologists：Intraocular and systemic manifestations. Ophthalmology 105：951-968, 1998

17）Schlötzer-Schrehardt U, Naumann GO：Trabecular meshwork in pseudoexfoliation syndrome with and without open-angle glaucoma：A monphometric, ultrastructural study. Invest Ophthalmol Vis Sci 36：1750-1764, 1995

18）Ritch R, Schlötzer-Schrehardt U, Konstas AG：Why is glaucoma associated with exfoliation syndrome? Prog Retin Eye Res 22：253-275, 2003

19）Khalil AK, Kubota T, Tawara A et al：Ultrastructural age-related changes on the posterior iris surface. A possible relation to the pathogenesis of exfoliation. Arch Ophthalmol 114：721-725, 1996

20）Asano N, Schlötzer-Schrehardt U, Naumann GO：A histopathologic study of iris changes in pseudoexfoliation syndrome. Ophthalmology 102：1279-1290, 1995

21）Schlötzer-Schrehardt U, Naumann GO：A histopathological study of zonular instability in pseudoexfoliation syndrome. Am J Ophthalmol 118：730-743, 1994

22）Miyake K, Matsuda M, Inaba M：Corneal endothelial changes in pseudoexfoliation syndrome. Am J Ophthalmol 108：49-52, 1989

23）Schlötzer-Schrehardt UM, Dörfler S, Naumann GO：Corneal endothelial involvement in pseudoexfoliation syndrome. Arch Ophthamol 111：666-674, 1993

24）Naumann GO, Schlötzer-Schrehardt U：Keratopathy in pseudoexfoliation syndrome as a cause of corneal endothelial decompensation. Ophthalmology 107：1111-1124, 2000

gene confer susceptibility to exfoliation glaucoma. Science 317：1397-1400, 2008

26）Aung T, Ozaki M, Mizoguchi T et al：A common variant mapping to CACNA1A is associated with susceptibility to exfoliation syndrome. Nat Genet, 47：387-392, 2015

27）Aung T, Ozaki M, Lee MC et al：Genetic association study of exfoliation syndrome identifies a protective rare variant at LOXL1 and five new susceptibility loci. Nat Genet 49：993-1004, 2017

28）Han X, Hewitt AW, MacGregor S：Predicting the future of genetic risk profiling of glaucoma：A narrative review. JAMA Ophthalmol 139：224-231, 2021

29）The Genetics of Exfoliation Syndrome（GenES）Partnership：Association of rare CYP39A1 variants with exfoliation syndrome involving the anterior chamber of the eye. JAMA 325：753-764, 2021

30）Bell K, Ozaki M, Mori K et al：Association of the CYP39A1G204E genetic variant with increased risk of glaucoma and blindness in patients with exfoliation syndrome. Ophthalmology 129：406-413, 2022

31）Terada Y, Kaburaki T, Takase H et al：Distinguishing features of anterior uveitis caused by herpes simplex virus, varicella-zoster virus, and cytomegalovirus. Am J Ophthalmol 227：191-200, 2021

32）Takase H, Kubono R, Terada Y et al：Comparison of the ocular characteristics of anterior uveitis caused by herpes simplex virus, varicella-zoster virus, and cytomegalovirus. Jpn J Ophthalmol 58：473-482, 2014

33）Nakano S, Sugita S, Tomaru Y et al：Establishment of multiplex solid-phase strip PCR test for detection of 24 ocular infectious disease pathogens. Invest Ophthalmol Vis Sci 58：1553-1559, 2017

34）Nakano S, Tomaru Y, Kubota T et al：Evaluation of a multiplex Strip PCR test for infectious uveitis：a prospective multi-center study. Am J Ophthalmol 213：252-259, 2020

35）Nakano S, Tomaru Y, Kubota T et al：Multiplex solid-phase real-time polymerase chain reaction without DNA extraction：A rapid intraoperative diagnosis using microvolumes. Ophthalmology 128：729-739, 2021

36）Otsuka T, Yokoyama K. Nakamuro T et al：Effect of continuous 0.5％ ganciclovir eye drop treatment in secondary glaucoma associated with cytomegalovirus anterior uveitis. Ophthalmology Research：An International Journal 14：13-21, 2021

37）嵜野祐二・横山勝彦・田村弘一郎・他：線維柱帯切除術の手術成績．臨眼76：1358-1364，2022

38）石部智也・嵜野祐二・久保田敏昭：線維柱帯切除術単独と水晶体再建併用線維柱帯切除術の手術成績の比較．臨眼76：607-612，2022

39）Tanito M, Sano I, Ikeda Y et al：Microhook ab interno trabeculotomy, a novel minimally invasive glaucoma surgery, in eyes with open-angle glaucoma with scleral thinning. Acta Ophthalmol 94：e371-e372, 2016

40）Tanito M, Sugihara K, Tsutsui A et al：Midterm results of microhook ab interno trabeculotomy in initial 560 eyes with glaucoma. J Clin Med 10：814, 2021

41）石部智也・八坂裕太・久保田敏昭：緑内障眼に対する白内障手術併用Ab Interno Trabeculotomyの手術成績．あたらしい眼科39：1417-1420，2022

42）Gazzard G, Konstantakopoulou E, Garway-Heath D et al：Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma（LiGHT）：a multicentre randomised controlled trial. Lancet 393：1505-1516, 2019

43）Miyazaki M, Kubota T, Kubo M et al：The prevalence of pseudoexfoliation syndrome in a Japanese population：the Hisayama Study. J Glaucoma 14：482-484, 2005

44）Fujiwara K, Yasuda M, Hata J et al：Prevalence of glaucoma and its systemic risk factors in a general Japanese population：the Hisayama Study. Transl Vis Sci Technol 11：11, 2022